IPECAD5 - Fifth International Pharmaco-Economic Conference on Alzheimer's Disease

Journal of Nutrition, Health and Aging

Volumn 14, Issue 5, 2010, Pages 358-360

  Gustavsson, Anders ^a,b   Jonsson, L ^b   Fillit, H ^c,d   Johansson, G ^a   Wimo, A ^a   Winblad, B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Innovus   (Sweden)

^c Alzheimer's Drug Discovery Foundation   (Sweden)

^d MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Alzheimer; Conference; Economics; Pharmaceuticals

Indexed keywords

ALZHEIMER DISEASE; CAREGIVER BURDEN; CLINICAL DECISION MAKING; COMORBIDITY; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DRUG INDUSTRY; HEALTH CARE ACCESS; HEALTH CARE COST; HUMAN; MARKET; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PERCEPTION; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; STANDARDIZATION;

EID: 77952736018     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12603-010-0080-3     Document Type: Conference Paper

References (7)

1. Wimo, A., B. Winblad, and L. Jonsson, An estimate of the total worldwide societal costs of dementia in 2005. Alzheimer's and Dementia, 2007. 3(2): p. 81-91.
2. Wimo, A., L. Jönsson, and B. Winblad., The worldwide prevalence and direct costs of dementia in 2003. Dementia and Geriatric Cognitive Disorders, in press., 2006.
3. Ferri, C.P., et al., Global prevalence of dementia: a Delphi consensus study. Lancet, 2005. 366(9503): p. 2112-2117
4. Dementia in Europe Yearbook 2006, Alzheimer Europe.
5. Wimo, A. and B. Winblad, Resource Utilization in dementia: RUD Lite. Brain & Aging, 2003. 3: p. p. 48-59.
6. Wimo, A. and G. Nordberg, Validity and reliability of assessments of time Comparisons of direct observations and estimates of time by the use of the resource utilization in dementia (RUD)-instrument. Arch Gerontol Geriatr, 2006.
7. Courtney, C., et al., Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet, 2004. 363(9427): p. 2105-2115